Select Page

The National Institutes of Health (NIH) launched clinical trials in July specifically designed to study interventions for the most common symptoms of Long COVID.  There are however some concerns about the likelihood of obtaining effective results.

The NIH Clinical Trials

Recognizing the urgent need to address Long COVID, the NIH has initiated a series of clinical trials aimed at investigating potential interventions for its most common symptoms. These trials focus on several key areas:

Fatigue and Cognitive Dysfunction: Long COVID often leaves individuals struggling with extreme fatigue and cognitive impairment. Clinical trials are evaluating medications, lifestyle interventions, and cognitive therapies to alleviate these symptoms.

Respiratory Issues: Trials are exploring therapies to improve lung function and address persistent shortness of breath and coughing in Long COVID patients.

Cardiovascular and Cardiopulmonary Symptoms: Given the prevalence of heart palpitations and chest pain, researchers are assessing medications and interventions to manage these symptoms effectively.

Pain and Joint Issues: Strategies for managing pain and joint problems are also under scrutiny, including physical therapy and pain management techniques.

Psychological and Emotional Well-being: Long COVID can take a toll on mental health. Trials are investigating therapies such as counseling, support groups, and mindfulness techniques to improve psychological well-being.

The Likelihood of Effective Results

While these NIH clinical trials represent a significant step forward in understanding and treating Long COVID, it is essential to recognize the complexity of the condition. Long COVID is not a one-size-fits-all disorder; its symptoms and severity can vary widely among individuals. This diversity poses several challenges when assessing the likelihood of obtaining effective results from these trials.

Diverse symptoms of Long COVID: What works for one patient may not work for another. It is crucial to acknowledge and address the very individual nature of these health challenges when interpreting trial results and developing treatment strategies.

Multifactorial Nature: Long COVID likely results from a combination of factors, including viral persistence, immune dysregulation, and neurological changes. This complexity makes it challenging to identify a single, magic-bullet treatment.

Potential for Symptom Overlap: Many Long COVID symptoms overlap with those of other chronic conditions, making it difficult to attribute improvements solely to the interventions being tested.

The Holistic Approach

The holistic approach to healing addresses each person as an individual and seeks to discover the underlying cause of their health issues. Long COVID is no exception. The barriers to healing that may be affecting the symptoms are most likely different from person to person.

Dr. Freddie Ulan’s recent research into post-pandemic factors has uncovered several barriers to healing that can be addressed with Nutrition Response Testing® and used to help the body heal. This testing takes a very personal approach and addresses each patient as an individual. Master Clinicians of Nutrition Response Testing are reporting excellent results with this protocol.

The UNS Fall Symposium will cover various holistic approaches to the post-pandemic health factors and how to improve the health of your patients.  Speakers include Dr. Ulan and Dr. Keith Shehan, who will be presenting his research on the role functional blood chemistry plays in patient health in a post-pandemic world.

UNS Fall Symposium information and registration


NIH clinical trials

Likelihood of results from the trials







Analytics Plugin created by Web Hosting